Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-10-21

Clinical Trial Update: Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses how food affects the pharmacokinetics of oral semaglutide in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rybelsus (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED